DUORHIN RUPATADINE/MONTELUKAST
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

DUORHIN RUPATADINE/MONTELUKAST Trademark

Serial Number: 79393721 • Registration: 7726350

DUORHIN RUPATADINE/MONTELUKAST is a trademark filed by INTAS THIRD PARTY SALES 2005 S.L. on January 17, 2024. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

INTAS THIRD PARTY SALES 2005 S.L.

Moll de Barcelona, s/n - World Trade Center,

Entity Type: 99

NOUCOR HEALTH, S.A.

Av. Cami Reial, 51-57

Entity Type: 85

Trademark Details

Filing Date

January 17, 2024

Registration Date

March 18, 2025

Published for Opposition

January 28, 2025

Goods & Services

Pharmaceutical products based on rupatadine and montelukast being pharmaceutical preparations for use as antihistamines

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Nov 15, 2025 FINO
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Oct 3, 2025 OPNX
GENERIC MADRID TRANSACTION SENT TO IB
Sep 29, 2025 XXSS
GENERIC MADRID TRANSACTION CREATED
Sep 29, 2025 XXCR
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Sep 17, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Sep 17, 2025 OPNR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jun 19, 2025 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Mar 18, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Mar 18, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 28, 2025 NPUB
PUBLISHED FOR OPPOSITION
Jan 28, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 22, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 26, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 25, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 25, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 25, 2024 TROA
REFUSAL PROCESSED BY IB
Sep 9, 2024 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Aug 22, 2024 RFCS
REFUSAL PROCESSED BY MPU
Aug 21, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Aug 16, 2024 RFCR
NON-FINAL ACTION WRITTEN
Aug 15, 2024 CNRT
ASSIGNED TO EXAMINER
Aug 12, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
Apr 23, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 19, 2024 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Apr 18, 2024 REPR